Company Overview

Ginkgo Bioworks (NYSE: DNA) is the leading synthetic biology platform, engineering organisms for applications in pharmaceuticals, agriculture, and industrial chemicals. Working toward adjusted EBITDA breakeven by end of 2026.

Revenue
$15000M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Ginkgo Bioworks is an emerging player bringing innovative solutions to the Healthcare market.

Enterprise Scale

With $15000M in revenue, Ginkgo Bioworks operates at enterprise scale with proven market validation.

Frequently Asked Questions

AI Visibility Rankings

How Ginkgo Bioworks performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Ginkgo Bioworks

See exactly how Ginkgo Bioworks ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Ginkgo Bioworks stacks up against competitors with our detailed comparison tool.

Start Comparison